About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,044 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,044 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5801-5820 of 8,044 trials

CompletedAlisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal MalignanciesThis is an open-label, multicenter study with a phase 1 dose escalation portion and a 2-stage, phase 2 portion, investigating MLN8237 (alisertib) in patients with advanced…NCT01045421·Houston, Texas and 1 other UnknownDeep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant ImmunochemotherapyThis study presents the development and validation of an artificial intelligence (AI) prediction system that utilizes pre-neoadjuvant immunotherapy plain scans and enhanced…NCT06285058 CompletedBody Composition and Inflammatory-Metabolic Indices in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer: The SARC-CTI StudyThis retrospective, single-center observational cohort study evaluates inflammatory-metabolic, cachexia-related, and computed tomography (CT)-derived body-composition markers in…NCT07192926·Ankara, Yenimahalle and 1 other

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedIntra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerThe purpose of this study is to determine the number of patients with advanced, relapsed non-small cell lung cancer who can tolerate dose escalation sorafenib from 400 mg twice…NCT00954278·Madison, Wisconsin

CompletedA Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response1. Trial design: Prospective observational study 2.NCT01523340·Hwasun

CompletedOSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung CancerThis study determines tumor response rate, time to tumor progression and survival rate at 1 year produced by OSI-774 in previously treated African American patients with nonsmall…NCT00230126·Columbus, Ohio

Active not recruitingClinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung CancerThe purpose of this study is to validate TNM-Immunoscore in resected non-small cell lung cancer.NCT03299478·Copenhagen, København Ø and 4 others

CompletedA Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With OsimertinibA multicentre, open-label, single-arm, molecular profiling study of patients with EGFR mutation-positive locally advanced or metastatic NSCLC treated with osimertinib.NCT03239340·Athens, Georgia and 25 others

UnknownClinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced MalignanciesClinical study BCD-201-1 is a double-blind randomized study of the pharmacokinetics (PK), pharmacodynamics (PD), safety, and immunogenicity of BCD-201 versus Keytruda following…NCT05739006·Moscow and 2 others

CompletedImmunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer PatientsThis study is designed to evaluate safety and immunogenicity of racotumomab in patients with advanced Non-small Cell Lung Cancer (NSCLC), in concomitance with chemotherapy…NCT01240447·Buenos Aires, Buenos Aires

TerminatedStudy of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)The purpose of this study is to estimate and compare the objective response rate of SPI-1620 administered in combination with docetaxel in patients with NSCLC and to determine the…NCT01741155·Cincinnati, Ohio and 4 others

CompletedStudy of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerThis Phase II study is to determine the efficacy of Thymosin α1 on the frequency of acute pneumonia in non-small cell lung cancer with bulky tumor.NCT03659578·Guangzhou, Guangdong

TerminatedStereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)To tested if the adding of consolidative SBRT to TKI in EGFR mutated patients with less than or equal to 5 metastatic sites (primary + 5) will improve progression free survival…NCT02893332·Chengdu, Sichuan

CompletedPhase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and CarboplatinThe purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the life of patients with squamous only non small cell lung cancer more…NCT02279732·Beijing, Beijing Municipality and 48 others

CompletedPhase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung CancerThe purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.NCT00040638·Tucson, Arizona and 2 others

TerminatedStudy of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung CancerThis study will evaluate progression free survival (PFS), overall survival (OS), objective response rate (ORR), duration of response, and safety of motesanib (AMG706) in…NCT02629848

UnknownStudy of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLCNon-small cell lung cancer has the highest morbidity and mortality in China，and platinum-based chemotherapy is the standard first-line treatment for the wild-type NSCLC,however…NCT03636685

RecruitingIBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerThis study is a single-arm, phase II clinical trial evaluating the safety and efficacy of IBI363 combined with chemotherapy as a neoadjuvant treatment of non-small cell lung…NCT07408635·Shanghai

RecruitingPh1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung CancerThe goal of this clinical research study is to find a safe and tolerable dose of navlimetostat in combination with pumitamig that can be given to patients with MTAP-deficient…NCT07579221·Houston, Texas

CompletedRandomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerThe purpose of this study is to determine if cisplatin-based chemotherapy, cisplatin-gemcitabine-ifosfamide or cisplatin-docetaxel, will improve survival in comparison to the…NCT00622349·Brussels and 3 others

PreviousPage 291 of 403Next